News
The flu virus is lingering in Arizona and the season has been vicious. Pediatric flu deaths reached the highest level in ...
Researchers have used high-throughput neutralisation assays to reveal how gaps in individual immunity shape the success of circulating flu strains.
This important study advances our understanding of population-level immune responses to influenza in both children and adults. The strength of the evidence supporting the conclusions is compelling, ...
The FDA’s approval was based on a study of 11,400 people ages 12 and older that compared the new low-dose vaccine with ...
Hydroxychloroquine (HCQ) use significantly lowers the risk for new-onset diabetes among patients with primary Sjögren syndrome (pSS), potentially mitigating the risks associated with high-dose ...
The latest flu season is over in Florida, with state data showing a high number of pediatric deaths and leaving some public health experts concerned for future seasons as vaccination rates fall.
Flu shots save lives across the United States every year. These vaccines are good at protecting the population from severe ...
Faricimab (Vabysmo) showed greater fluid reduction compared with high-dose aflibercept (Eylea) at 12 weeks in matched analyses of diabetic macular edema (DME) and age-related macular degeneration ...
No other flu vaccine production approach can produce doses with the speed of the messenger RNA platform used by Moderna and other companies that work with mRNA. But the vaccine platform is viewed ...
(Fluzone, a high-dose flu shot, is approved for adults ages 65 and older and some younger people with weakened immune systems.) The researchers sampled the trial participants' blood at Day 1 and ...
Late-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results